Amyloidosis trials in China

In China 38 Also abroad 184

38 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
Where
Beijing, Tianjin
Age
18 years and over
People
90
Run by
Keymed Biosciences Co.Ltd
See details and how to joinNCT07039578
Phase 4Taking people
A Prospective Cohort Study on Primary Cutaneous Amyloidosis
Where
Chongqing
Age
18 years and over
People
56
Run by
Army Medical University, China
See details and how to joinNCT06998875
Phase 4Taking people
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Where
Jinan
Age
18 years to 80 years
People
15
Run by
Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT06940336
Early phase 1Taking people
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Where
Hefei
Age
19 years to 75 years
People
36
Run by
Anhui Provincial Hospital
See details and how to joinNCT07085559
Phase 2Taking people
Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
Where
Beijing
Age
18 years and over
People
35
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07079423
Phase 2Taking people
Teclistamab in Previously Treated AL Amyloidosis
Where
Beijing
Age
18 years and over
People
30
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06935162
No phaseTaking people
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
Where
Beijing
People
20
Run by
Peking University People's Hospital
See details and how to joinNCT06699394
Early phase 1Taking people
Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy
Where
Hangzhou
Age
18 years to 80 years
People
7
Run by
Zhejiang University
See details and how to joinNCT06082050
Phase 2Taking people
Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
Where
Beijing
Age
18 years to 90 years
People
40
Run by
Jin Lu, MD
See details and how to joinNCT06342466
No phaseTaking people
Daratumumab for Patients With Light Chain Amyloidosis
Where
Nanjing
Age
18 years to 75 years
People
100
Run by
Nanjing University School of Medicine
See details and how to joinNCT06376214
No phaseEnrolling by invitation
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis
Where
Nanjing
Age
18 years to 75 years
People
500
Run by
Nanjing University School of Medicine
See details and how to joinNCT04210791
No phaseTaking people
Clinical Study for AL-CM
Where
Hangzhou
Age
18 years to 80 years
People
400
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04924998
Phase 4Taking people
Clinical Study of ATTR-CM
Where
Hangzhou
Age
18 years to 80 years
People
100
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04935021